The new weekly formulation of setmelanotide, Rhythm Pharmaceuticals’ lead candidate for rare genetic obesity…
Articles by Joana Carvalho, PhD
Two variants of the Alström syndrome 1 (ALMS1) gene can increase the risk of heart attack in Chinese…
Two gene variants normally associated with type 2 diabetes risk are also linked to obesity in an Egyptian…
Obesity is associated with brain structural abnormalities in healthy individuals, as well as in those with major depressive disorder…
Air pollution may be associated with obesity and body fat percentage, according to a comprehensive new study from the United…
Rhythm Pharmaceuticals remains on track to file a new drug application (NDA) with the U.S. Food and Drug…
Unlike height, body mass index (BMI) and other obesity-related traits are strongly influenced by interactions between an individual’s genetic…
Scientists discovered gene variants that increase the risk of excessive weight gain in women during pregnancy, which is directly associated…
By looking at the genetic backgrounds of nearly 30,000 individuals from different ethnic groups, scientists have identified a new genetic…
Two ongoing Phase 3 clinical trials assessing the effects of setmelanotide as an obesity treatment for patients with…